Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
NCT01878435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2018
Last updated 2022-10-27
Summary
The project goal is to conduct a randomized controlled trial (RCT) to test whether mobile phone short message system (SMS) reminders, either with or without mobile-phone based travel subsidies will improve timeliness, coverage, and drop-out rates of routine EPI vaccines in rural western Kenya.
Conditions
- Diphtheria
- Tetanus
- Pertussis
- Hepatitis B
- Haemophilus Influenzae Type b
- Measles
Interventions
- OTHER
-
SMS reminder
- OTHER
-
Travel subsidy
- OTHER
-
Travel subsidy 2
Sponsors & Collaborators
-
Bill and Melinda Gates Foundation
collaborator OTHER -
Kenya Medical Research Institute
collaborator OTHER -
Centers for Disease Control and Prevention
collaborator FED -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Weeks
- Max Age
- 5 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- Kenya
More Related Trials
-
Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
NCT00263692 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
NCT04638985 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life
NCT02111135 ·Status: COMPLETED ·Phase: PHASE2
-
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
NCT03821441 ·Status: UNKNOWN ·Phase: PHASE3
-
Persistence of IPV Immunity
NCT03723837 ·Status: COMPLETED ·Phase: PHASE4
-
SMS Mobile Technology for Vaccine Coverage and Acceptance
NCT01663636 ·Status: COMPLETED
-
Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA
NCT04636827 ·Status: UNKNOWN ·Phase: PHASE4
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
NCT00404651 ·Status: COMPLETED ·Phase: PHASE3
-
The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)
NCT02231632 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
NCT02274285 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children
NCT00228917 ·Status: COMPLETED ·Phase: PHASE3
-
Ontogeny of Measles Immunity in Infants
NCT00240916 ·Status: COMPLETED
-
Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
NCT01025544 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India
NCT04010448 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine
NCT01831050 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines
NCT03274102 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
NCT06331702 ·Status: COMPLETED ·Phase: PHASE4
-
Zambia SiVET MMR Tdap-IPV
NCT02589678 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
NCT00291343 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
NCT05161845 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
NCT04941261 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Concomitant Administration of the sIPV and DTaP or MMR
NCT06920069 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4